adult
mice
treat
dextran
sulfat
sodium
dss
infect
citrobact
rodentium
develop
novel
murin
coliti
model
mice
divid
four
group
group
compos
control
dextran
sodium
sulfatetr
dss
c
rodentiuminfect
ct
dsstreat
c
rodentiuminfect
dssct
mice
dss
group
administ
dss
drink
water
day
ct
group
suppli
normal
drink
water
day
subsequ
infect
c
rodentium
via
oral
gavag
dssct
group
suppli
dss
drink
water
day
subsequ
infect
c
rodentium
via
oral
gavag
mice
sacrif
day
induct
c
rodentium
infect
dssct
group
display
significantli
shorter
colon
length
higher
spleen
bodi
weight
ratio
higher
histopatholog
score
compar
three
group
mrna
express
level
tumor
necrosi
factor
tnf
interferon
inf
significantli
upregul
howev
interleukin
il
significantli
downregul
dssct
group
control
group
result
demonstr
combin
low
dss
concentr
c
rodentium
infect
could
effect
induc
inflammatori
bowel
diseas
ibd
mice
may
potenti
use
novel
ibd
model
coliti
induc
mice
combin
chemic
pathogen
inflammatori
bowel
diseas
ibd
ulcer
coliti
uc
crohn
diseas
cd
import
type
human
enter
character
chronic
relaps
recurr
inflammatori
condit
result
chronic
dysregul
mucos
immun
system
gastrointestin
tract
bauer
et
al
exact
mechan
underli
pathogenesi
ibd
unknown
howev
wide
known
infect
immunolog
abnorm
genet
environment
factor
import
determin
ibd
kwon
et
al
past
decad
numer
anim
model
ibd
develop
includ
spontan
coliti
model
adopt
transfer
model
genet
modifi
model
induc
coliti
model
cerar
due
simplic
induct
reproduc
chemic
induc
murin
intestin
inflamm
model
develop
use
dextran
sulfat
sodium
dss
trinitrobenzen
sulfon
acid
oxazolon
acet
acid
nonsteroid
antiinflammatori
drug
wide
use
randhawa
et
al
especi
dssinduc
ibd
model
wide
use
simplic
similar
human
ibd
kim
et
al
chassa
et
al
dss
watersolubl
neg
charg
sulfat
polysaccharid
molecular
weight
rang
kda
chassa
et
al
molecular
weight
dss
import
factor
induct
coliti
mice
rat
sever
coliti
result
use
kda
dss
hirono
et
al
axelsson
et
al
kitajima
et
al
gener
dss
concentr
administr
dissolv
drink
water
produc
either
acut
chronic
coliti
depend
experiment
protocol
chassa
et
al
administr
dss
result
symptom
like
loos
stool
diarrhea
bloodi
fece
bodi
weight
loss
mucos
ulcer
shorten
colon
rectum
kwon
et
al
dssinduc
coliti
cytokin
level
tumor
necrosi
factor
tnf
interleukin
il
upregul
randhawa
et
al
citrobact
rodentium
previous
known
citrobact
freundii
biotyp
citrobact
speci
gramneg
rodshap
bacterium
caus
agent
transmiss
murin
colon
hyperplasia
natur
occur
pathogen
laboratori
mice
mice
character
epitheli
cell
hyperprolifer
descend
colon
luperchio
schauer
c
rodentium
transmit
fecalor
rout
colon
gastrointestin
tract
follow
migrat
cecum
colon
via
format
attach
effac
ae
lesion
alipour
et
al
enteropathogen
escherichia
forti
mice
divid
four
group
micegroup
pretreat
dextran
sulfat
sodium
dss
normal
drink
water
week
subsequ
inocul
c
rodentium
fresh
lb
broth
mice
sacrif
day
induct
c
rodentium
infect
b
bodi
weight
measur
everi
day
plot
percentag
initi
bodi
weight
mous
data
express
mean
p
compar
control
dss
group
coli
epec
etiolog
agent
infantil
diarrhea
enterohemorrhag
e
coli
ehec
caus
agent
hemorrhag
diarrhea
hemolyt
uret
syndrom
member
ae
famili
deng
et
al
wherea
epec
ehec
poorli
pathogen
mous
intestin
epitheli
cell
c
rodentium
much
better
aelesionform
pathogen
compar
e
coli
c
rodentium
infect
result
deplet
goblet
cell
crypt
cell
hyperplasia
inflammatori
cell
infiltr
signific
intestin
barrier
disrupt
mous
model
luperchio
schauer
mundi
et
al
c
rodentiuminfect
mice
develop
variou
patholog
depend
age
genet
background
diet
indigen
microbiota
mundi
et
al
c
rodentium
infect
suckl
immunodefici
mice
result
develop
coliti
character
diarrhea
rectal
prolaps
clinic
sign
includ
retard
growth
listless
dehydr
mortal
sever
case
luperchio
schauer
ryu
et
al
contrast
infect
adult
mice
subclin
selflimit
result
consider
less
morbid
mortal
maaser
et
al
therefor
difficult
induc
coliti
use
c
rodentium
adult
mice
sever
studi
relat
develop
coliti
model
mice
use
chemic
pathogen
report
howev
studi
report
simultan
usag
main
purpos
studi
induc
coliti
use
chemic
pathogen
alon
use
togeth
studi
novel
coliti
mous
model
develop
administr
low
concentr
dss
day
subsequ
follow
infect
c
rodentium
procedur
approv
institut
anim
care
use
committe
konkuk
univers
sixweekold
femal
mice
purchas
koatech
co
ltd
mice
acclimat
one
week
laboratori
anim
breed
room
colleg
veterinari
medicin
konkuk
univers
mice
hous
steril
polycarbon
cage
wire
lid
steril
bed
filter
cage
top
control
pathogenfre
condit
light
dark
cycl
humid
mice
fed
steril
food
water
ad
libitum
c
rodentium
strain
db
atcc
inocul
luriabertani
lb
agar
allow
grow
overnight
subsequ
cultur
lb
broth
overnight
cultur
broth
centrifug
g
min
centrifug
bacteri
pellet
resuspend
fresh
lb
medium
mice
infect
ml
lb
medium
contain
cfu
via
oral
gavag
cfuml
determin
plate
serial
dilut
studi
molecular
weight
rang
dss
mp
biomed
inc
use
kda
low
concentr
dss
solut
prepar
steril
drink
water
administr
ad
libitum
one
week
acclim
mice
divid
four
group
mice
administ
dss
normal
drink
water
week
infect
fig
weight
spleen
length
colon
bodi
weight
spleen
weight
colon
length
measur
experi
n
mice
per
group
spleen
bodi
weight
ratio
b
colon
length
data
express
mean
sd
p
compar
control
group
p
compar
dss
group
p
p
compar
ct
group
c
rodentium
via
oral
gavag
fast
h
prior
c
rodentium
infect
control
group
suppli
normal
drink
water
day
inocul
fresh
lb
broth
seventh
day
start
experi
dss
group
administ
dss
normal
drink
water
day
inocul
fresh
lb
broth
seventh
day
ct
group
administ
normal
drink
water
day
infect
c
rodentium
seventh
day
via
oral
gavag
dssct
group
administ
dss
normal
drink
water
day
infect
c
rodentium
seventh
day
via
oral
gavag
fig
bodi
weight
mice
record
everi
day
mice
euthan
seventeen
day
experi
spleen
remov
weigh
store
analysi
entir
larg
intestin
collect
length
colon
measur
portion
mid
distal
colon
fix
buffer
formalin
dehydr
use
gradient
ethanol
clarifi
xylen
embed
paraffin
embed
paraffin
block
cut
section
stain
hematoxylin
eosin
h
e
quantif
histopatholog
perform
imag
use
metamorph
computer
imag
analysi
softwar
molecular
devic
select
section
score
two
blind
investig
colon
histopatholog
score
describ
previous
rath
et
al
slight
modif
tabl
tissu
section
assess
goblet
cell
deplet
score
base
number
goblet
cell
per
highpow
field
magnif
cell
mucos
thicken
inflammatori
cell
mucosa
submucosa
score
base
number
inflammatori
cell
mucosa
submucosa
per
highpow
field
magnif
cell
total
rna
extract
store
spleen
tissu
use
rneasi
mini
kit
qiagen
accord
manufactur
instruct
rna
quantit
determin
absorb
optic
densiti
od
nm
assess
puriti
measur
ratio
absorb
nm
direct
examin
rna
band
agaros
gel
equal
amount
rna
revers
transcrib
cdna
use
mmlv
revers
transcriptas
invitrogen
briefli
total
rna
extract
tissu
revers
transcrib
reaction
mixtur
contain
rt
buffer
oligo
dt
primer
dntp
mix
mm
rnaseout
tm
firststrand
buffer
dtt
mmlv
revers
transcriptas
cdna
use
templat
realtim
pcr
realtim
pcr
perform
use
biorad
realtim
pcr
detect
system
biorad
accord
manufactur
instruct
taqman
tm
fluorogen
probe
pcr
primer
monocyt
chemoattract
gapdh
obtain
biorad
threshold
cycl
ct
correl
invers
target
mrna
express
level
measur
cycl
number
report
fluoresc
emiss
increas
threshold
level
rel
chang
mrna
level
normal
level
gapdh
mrna
sampl
data
obtain
studi
analyz
use
graphpad
prism
softwar
graphpad
softwar
inc
data
score
express
mean
sd
p
p
compar
control
group
p
p
compar
dss
group
p
p
compar
ct
group
express
mean
standard
deviat
sd
result
consid
statist
signific
p
p
bodi
weight
mice
measur
everi
day
mous
chang
bodi
weight
calcul
percentag
initi
weight
fig
group
gain
bodi
weight
gradual
increas
day
start
experi
subsequ
seventh
day
decreas
group
due
fast
mice
fast
h
increas
infect
c
rodentium
differ
gain
bodi
weight
observ
among
group
prior
c
rodentium
infect
howev
c
rodentium
infect
bodi
weight
gain
dssct
group
significantli
p
lower
control
dss
group
dssct
group
display
significantli
p
higher
spleen
bodi
weight
ratio
compar
ct
group
significantli
p
higher
spleen
bodi
weight
ratio
control
dss
group
fig
ratio
spleen
bodi
weight
also
significantli
p
higher
ct
group
control
dss
group
entir
colon
length
also
measur
mice
sacrif
dssct
group
display
significantli
p
shorter
colon
length
cm
compar
control
cm
dss
cm
ct
cm
group
fig
differ
colon
length
observ
among
control
dss
ct
group
disrupt
hyperplasia
mucosa
import
indic
coliti
dssct
group
histopatholog
lesion
colon
character
loss
goblet
cell
mucos
thicken
infiltr
inflammatori
cell
mucosa
submucosa
fig
supplementari
data
fig
histopatholog
lesion
examin
independ
two
pathologist
evalu
use
score
system
dss
ct
group
loss
goblet
cell
mucos
thicken
infiltr
inflammatori
measur
use
realtim
pcr
mrna
express
level
normal
gapdh
mrna
level
sampl
score
express
mean
standard
error
p
p
compar
control
group
p
p
compar
dss
group
p
p
compar
ct
group
cell
slightli
increas
compar
control
group
four
histopatholog
score
includ
loss
goblet
cell
mucos
thicken
infiltr
inflammatori
cell
mucosa
submucosa
significantli
p
higher
mid
distal
region
colon
dssct
group
compar
three
group
fig
ct
group
also
display
significantli
p
higher
histopatholog
score
distal
colon
region
compar
control
dss
group
fig
contrast
distal
colon
region
ct
group
mid
colon
region
display
significantli
p
higher
histopatholog
score
control
group
total
histopatholog
score
express
sum
individu
histopatholog
score
total
histopatholog
score
mid
distal
colon
region
dssct
group
respect
significantli
p
higher
compar
three
group
total
histopatholog
score
mid
distal
colon
region
ct
group
respect
also
significantli
p
higher
control
dss
group
differ
total
histopatholog
score
mid
distal
colon
region
observ
control
respect
dss
respect
group
mrna
express
level
evalu
spleen
use
realtim
pcr
mrna
express
level
proinflammatori
cytokin
includ
significantli
p
higher
dssct
group
compar
three
group
fig
b
hand
mrna
express
level
antiinflammatori
cytokin
significantli
p
lower
dssct
group
compar
control
ct
group
fig
interestingli
compar
control
group
mrna
express
level
chang
ct
group
howev
level
significantli
p
decreas
dss
group
fig
mrna
express
level
significantli
p
lower
dss
group
control
group
mrna
express
higher
group
control
group
howev
signific
differ
observ
group
fig
f
although
numer
coliti
model
induc
use
dss
develop
suscept
dss
depend
speci
anim
use
mice
rat
coliti
develop
primarili
colon
howev
guinea
pig
lesion
develop
mainli
cecum
okayasu
et
al
iwanaga
et
al
hoshi
et
al
addit
symptom
coliti
also
vari
accord
molecular
weight
dss
use
chassa
et
al
acut
chronic
coliti
usual
induc
continu
administr
dss
day
cyclic
dss
treatment
kwon
et
al
cerar
use
chemic
pathogen
induc
murin
coliti
unlik
previou
studi
treat
mice
low
dose
dss
c
rodentium
thu
studi
establish
novel
model
ibd
induc
use
dss
c
rodentium
ibd
becom
increasingli
preval
affect
per
peopl
worldwid
casati
toner
although
occur
age
peak
age
onset
ibd
year
symptom
ibd
includ
chronic
uncontrol
inflamm
intestin
mucosa
affect
part
gastrointestin
tract
andr
friedman
hanauer
howev
mechan
dss
induc
coliti
yet
elucid
interestingli
variou
studi
shown
dss
administr
induc
toxic
effect
colon
epithelium
caus
alter
lumin
bacteri
flora
activ
cell
b
cell
macrophagemedi
inflammatori
respons
okayasu
et
al
yamada
et
al
ohkusa
et
al
clinic
signific
pathogen
strain
epec
ehec
also
link
ibd
epec
ehec
known
induc
ae
lesion
intim
attach
apic
host
cell
membran
cecal
colon
epithelium
therebi
form
noninvas
pedestallik
structur
eckmann
howev
mice
suscept
epec
epec
infect
c
rodentium
ae
pathogen
caus
agent
transmiss
murin
colon
hyperplasia
natur
occur
diseas
mice
luperchio
schauer
mundi
et
al
oral
c
rodentium
infect
mice
caus
transient
colon
cecum
progress
distal
colon
day
infect
peak
week
subsequ
infect
get
clear
next
week
macdonald
et
al
eckmann
c
rodentiuminduc
typhliti
coliti
difficult
induc
adult
mice
mous
strain
resist
c
rodentium
infect
simmon
et
al
establish
novel
ibd
model
adult
mice
determin
percent
dss
optimum
dose
c
rodentium
conduct
preliminari
experi
experiment
coliti
adult
mice
induc
administr
dss
week
follow
infect
highdos
cfu
c
rodentium
follow
pretreat
dss
infect
use
cfu
c
rodentium
success
ibd
model
establish
mice
die
supplementari
data
fig
studi
success
develop
coliti
model
use
adult
mice
mice
pretreat
dss
day
subsequ
infect
cfu
c
rodentium
induct
c
rodentium
infect
gain
bodi
weight
significantli
reduc
dssct
group
compar
control
group
howev
signific
differ
gain
bodi
weight
observ
dss
ct
group
compar
control
group
unlik
previou
studi
wu
et
al
knod
et
al
studi
bodi
weight
increas
steadili
except
fast
period
even
dssct
group
use
dss
low
dose
c
rodentium
hypertrophi
spleen
hyperplasia
shorten
larg
intestin
observ
mice
infect
c
rodentium
gibson
et
al
consist
previou
report
dssct
group
spleen
bodi
weight
ratio
significantli
increas
colon
length
significantli
shorten
compar
three
group
disrupt
cell
morpholog
characterist
observ
c
rodentiuminfect
mice
loss
goblet
cell
mucos
hyperplasia
dramat
infiltr
inflammatori
cell
mucosa
submucosa
luperchio
schauer
histopatholog
loss
crypt
infiltr
inflammatori
cell
mucosa
submucosa
submucos
edema
eros
ulcer
observ
murin
coliti
induc
dss
kitajima
et
al
consist
previou
observ
signific
deplet
goblet
cell
mucos
hyperplasia
infiltr
inflammatori
cell
observ
mid
distal
colon
region
dssct
group
mice
compar
mice
three
group
result
suggest
c
rodentium
infect
follow
administr
dss
caus
morpholog
alter
colon
predominantli
produc
natur
killer
nk
cell
act
mediat
macrophag
activ
immunolog
respons
flynn
et
al
proinflammatori
cytokin
divers
biolog
effect
includ
cytolysi
cytotox
immunoregul
cellular
prolifer
antivir
respons
thu
action
worsen
diseas
condit
yu
et
al
antiinflammatori
cytokin
predominantli
produc
monocyt
macrophag
cell
includ
type
helper
cell
b
cell
moor
et
al
interestingli
primarili
produc
cell
b
cell
monocyt
pmn
act
proand
antiinflammatori
cytokin
immun
respons
scheller
et
al
mrna
level
colon
significantli
higher
mice
coliti
induc
use
dss
compar
untreat
control
group
mice
ouyang
et
al
sang
et
al
contrari
previou
studi
mrna
level
spleen
chang
dss
group
howev
mrna
level
dramat
decreas
dss
group
compar
level
control
group
may
due
concentr
dss
use
durat
administr
coliti
model
induc
use
dss
c
rodentium
mrna
express
level
significantli
higher
dssct
group
three
group
contrast
mrna
express
level
significantli
lower
dssct
group
control
ct
group
data
show
low
concentr
dss
c
rodentium
infect
inhibit
express
cytokin
includ
howev
novel
model
increas
level
proinflammatori
cytokin
name
due
c
rodentium
infect
result
suggest
coliti
model
immunolog
balanc
proand
antiinflammatori
cytokin
maintain
thu
novel
anim
model
ibd
summari
administr
low
concentr
dss
adult
mice
day
subsequ
infect
c
rodentium
via
oral
gavag
mice
show
less
bodi
weight
gain
shorten
colon
length
increas
spleen
weight
sever
histopatholog
lesion
includ
deplet
goblet
cell
mucos
hyperplasia
inflammatori
cell
infiltr
express
level
increas
decreas
dssct
group
compar
control
group
conclus
novel
murin
ibd
model
effect
develop
combin
low
concentr
dss
c
rodentium
infect
knowledg
first
studi
demonstr
induct
coliti
mice
use
combin
chemic
pathogen
